Quercetin Derivatives for Enhanced Solubility and Anti-Tumor Activity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for malignant tumors, particularly epithelial tumors and carcinomas, face limitations due to low solubility, low absorption, and rapid metabolism of quercetin, a natural flavonoid with anti-neoplastic properties, which restricts its therapeutic potential.

Innovation Solution

Development of synthetic flavone derivatives with enhanced bioavailability and biological activity, including quercetin ethers and esters, and quercetin-NAE hybrid structures, designed to improve solubility and metabolic stability, thereby increasing their effectiveness against malignant tumors.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If quercetin is used as an anti-neoplastic agent, then anti-tumour activity is achieved, but solubility and bioavailability are insufficient

Engineering Contradiction:
Improveanti-tumour activityVSAvoidsolubility and bioavailability
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent applies parameter changes by modifying the chemical structure of quercetin through esterification with fatty acids. This transforms quercetin from a poorly soluble compound to water-soluble derivatives (e.g., quercetin palmitate, quercetin stearate) while preserving the core flavonoid structure responsible for anti-neoplastic activity. The ester groups enhance solubility and metabolic stability without eliminating the biological activity.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates composite molecular structures by combining quercetin with fatty acid chains. These hybrid molecules integrate the anti-cancer properties of quercetin with the solubility-enhancing and membrane-permeating characteristics of lipid chains, resulting in a composite agent that overcomes the limitations of pure quercetin.

Inventive Principle:
Principle #40Composite materials

2Reliability

If quercetin is administered orally, then anti-neoplastic effects are achieved, but rapid metabolism limits therapeutic potential

Engineering Contradiction:
Improveanti-neoplastic effectsVSAvoidmetabolic stability
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The esterification modification changes the metabolic parameters of quercetin. The fatty acid esters are metabolically more stable than the parent compound, allowing prolonged circulation and sustained anti-neoplastic effects. The modified molecules resist rapid enzymatic degradation while maintaining the ability to inhibit cell proliferation and induce apoptosis in tumor cells.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If chemo- and radio-therapy are used to treat malignant tumors, then tumor growth is inhibited, but severe side effects occur

Engineering Contradiction:
Improvetumor growth inhibitionVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The quercetin derivatives exhibit selective toxicity toward neoplastic cells while sparing normal tissues. The modified molecules concentrate in tumor cells where they inhibit proliferation and induce apoptosis, while their selective action profile results in significantly reduced side effects compared to conventional chemotherapy and radiotherapy.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These derivatives exhibit improved solubility and bioavailability, leading to enhanced anti-neoplastic effects by inhibiting cell growth, inducing apoptosis, and disrupting metastatic processes, offering a more effective treatment for various types of cancers and additional therapeutic benefits.

Implementation Method 1

Induction of apoptosis: apoptosis, or programmed cell death, is essential in the homeostasis of the human body. Dysregulation and defects in apoptotic processes lead to the development of neoplasms. Quercetin has been shown to increase the synthesis of pro-apoptotic factors in mammary and colorectal carcinoma cell lines.

Methodology Applied
Scientific EffectApoptosis:

Implementation Method 2

Inhibition of the metastatic process: the metastatic process is closely linked to the production of metalloproteinases (MMPs), which are enzymes responsible for extracellular matrix degradation and invasion of surrounding tissues by tumour cells. Several studies have analysed the potential of quercetin in the inhibition of MMPs.

Methodology Applied
Scientific EffectMetalloproteinase inhibition:

Implementation Method 3

The molecular mechanisms involved appear to be the modulation of pro-proliferative intracellular cascades such as PI3K/akt, Her-2/neu, Wnt/beta-catenin, and EGFR. Quercetin appears to inhibit the activity of mammalian Target Of Rapamycin (mTOR), which is hyperactive in neoplastic cells and essential in controlling intracellular growth signals.

Methodology Applied
Scientific EffectSignal transduction modulation:

Data Source

PatentUS12059400B2Medical compound
Publication Date: 2024.08.13 VERA SALUS RICERCA SRL
  • US12059400B2 patent drawing
  • US12059400B2 patent drawing
  • US12059400B2 patent drawing

AI summary

Provided is a medical compound including a synthetic flavone derivative, according to the formula (I) with allotment in position C-3 of a group as shown below:wherein at least two of R2-R6 are H, and the remaining are independently selected from: H, OH, R1, OR1, NO2, NH2, NHR1, F, Cl, Br, I, where R1 is a radical.